Hot Takeover Rumors

Discussion in 'Bristol-Myers Squibb' started by anonymous, Feb 14, 2017 at 3:39 PM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    "By Ben Levisohn- Barrons
    I hate reporting on rumors, especially ones based on unnamed sources. But when a stock is moving because of said rumor, do I have much of a choice? Which brings me to Bristol-Myers Squibb. Its shares have dropped 30% during the past seven months due to the failure of a cancer-drug trial. Since then analysts have begun speculating about the possibility that Bristol-Myers could be a takeover target, and now we have rumors, reported by StreetInsider.com, that Roche, Novartis, and Pfizer are actively exploring a takeover, while Gilead Sciences might be considering the idea."
     

  2. anonymous

    anonymous Guest

    Buh bye...
     
  3. anonymous

    anonymous Guest

     
  4. anonymous

    anonymous Guest

    We've been circling the drain for a long time. Pharma is contracting and soon ther will be 5-10 big companies
     
  5. anonymous

    anonymous Guest

    I heard AstraZeneca was interested in taking over the #hitpile!
     
  6. anonymous

    anonymous Guest

    Step up to the plate any and all are welcome .. the bidding starts at 100 billion but do t expect to get it that cheap .

    .21 oncology drugs in the pipeline to go with opdivo which is already a multi billion dollar drug..

    Giles is a desperate company with 0 pipeline so if they will pay 110 billion let's do it ..

    I have plenty of bmy stock and options so let's go!!!
     
  7. anonymous

    anonymous Guest

     
  8. anonymous

    anonymous Guest

    Been hearing this since 1993.
     
  9. anonymous

    anonymous Guest

    Oh God, no. I know people over there. It is a shit show. Morale is worse than here and senior leaders literally told their PCP sales force that they had 12 weeks to move share w/ the drug or else. Who does that at a launch meeting? The proverbial frying pan into the fire.